UnitedHealth Group Incorporated $UNH Stock Position Increased by Sivia Capital Partners LLC

Sivia Capital Partners LLC boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 113.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,832 shares of the healthcare conglomerate’s stock after acquiring an additional 2,035 shares during the quarter. Sivia Capital Partners LLC’s holdings in UnitedHealth Group were worth $1,323,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also added to or reduced their stakes in UNH. Clark Asset Management LLC acquired a new stake in shares of UnitedHealth Group during the 3rd quarter valued at $225,000. Simplify Asset Management Inc. lifted its position in shares of UnitedHealth Group by 624.8% in the 3rd quarter. Simplify Asset Management Inc. now owns 29,360 shares of the healthcare conglomerate’s stock valued at $10,138,000 after acquiring an additional 25,309 shares in the last quarter. LVW Advisors LLC grew its position in UnitedHealth Group by 22.9% during the 3rd quarter. LVW Advisors LLC now owns 1,782 shares of the healthcare conglomerate’s stock worth $615,000 after purchasing an additional 332 shares in the last quarter. Rooted Wealth Advisors Inc. lifted its holdings in shares of UnitedHealth Group by 35.3% in the third quarter. Rooted Wealth Advisors Inc. now owns 2,557 shares of the healthcare conglomerate’s stock valued at $921,000 after purchasing an additional 667 shares in the last quarter. Finally, waypoint wealth counsel grew its holdings in shares of UnitedHealth Group by 62.0% during the third quarter. waypoint wealth counsel now owns 1,748 shares of the healthcare conglomerate’s stock valued at $604,000 after buying an additional 669 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Down 0.9%

Shares of UNH stock opened at $328.85 on Tuesday. The company has a market capitalization of $297.88 billion, a price-to-earnings ratio of 17.16, a PEG ratio of 2.16 and a beta of 0.43. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.82 and a current ratio of 0.82. The stock’s 50 day simple moving average is $333.00 and its 200 day simple moving average is $319.23. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $606.36.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The company had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. During the same quarter last year, the firm posted $7.15 earnings per share. The company’s quarterly revenue was up 12.2% compared to the same quarter last year. As a group, research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 16th. Investors of record on Monday, December 8th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.7%. The ex-dividend date was Monday, December 8th. UnitedHealth Group’s dividend payout ratio is presently 46.14%.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the company. The Goldman Sachs Group assumed coverage on UnitedHealth Group in a report on Tuesday, October 14th. They issued a “buy” rating and a $406.00 target price on the stock. KeyCorp increased their target price on shares of UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 8th. Wells Fargo & Company upped their price target on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 7th. Weiss Ratings raised UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, October 24th. Finally, TD Cowen raised their price target on UnitedHealth Group from $335.00 to $338.00 and gave the stock a “hold” rating in a research note on Thursday, October 30th. Seventeen analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $385.54.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.